{"id":21363,"date":"2017-07-12T14:00:34","date_gmt":"2017-07-12T14:00:34","guid":{"rendered":"https:\/\/ipo.org\/?p=21363"},"modified":"2017-08-07T17:24:51","modified_gmt":"2017-08-07T17:24:51","slug":"will-dance-now-biosimilars-after%e2%80%afamgen-v-sandoz","status":"publish","type":"post","link":"https:\/\/ipo.org\/index.php\/will-dance-now-biosimilars-after%e2%80%afamgen-v-sandoz\/","title":{"rendered":"Who Will “Dance” Now?\u00a0Biosimilars\u00a0After\u202fAmgen v. Sandoz\u00a0"},"content":{"rendered":"
\n
\n

Developers for\u00a0<\/span><\/span>biosimilars<\/span><\/span>\u00a0face not only stiff technical and manufacturing challenges, but also legal uncertainty regarding the enabling legal framework, the Biologics Price Competition and Innovation Act (BPCIA) of 2010. Two of those questions — regarding the availability of a federal injunction to compel information disclosure and the timing of the biosimilar maker’s notice of marketing — were answered in last month’s U.S. Supreme Court opinion on two cases between Amgen and Sandoz.<\/span><\/span>\u00a0<\/span>
\n<\/span><\/p>\n<\/div>\n

\n

But much remains uncertain. Our panel of top drug industry litigators will give their views on what lies ahead regarding such questions as:<\/span><\/span>\u00a0<\/span><\/p>\n<\/div>\n

    \n
  • Will the “patent dance” be essentially mandatory under state law? Will availability of an injunction vary by state, perhaps triggering important venue issues?<\/span><\/span>\u00a0<\/span><\/li>\n
  • When would a biosimilar maker choose the patent dance even if it is not mandatory?<\/span><\/span>\u00a0<\/span><\/li>\n
  • How soon can a biosimilar manufacturer give notice of commercial marketing? Can it be done before filing for FDA approval?<\/span><\/span>\u00a0<\/span><\/li>\n<\/ul>\n
    \n

    <\/span><\/span>\u00a0<\/span>Speakers:<\/span><\/span>\u00a0<\/span><\/p>\n<\/div>\n<\/div>\n

    \n
      \n
    • Elaine\u00a0<\/span><\/span><\/span>Blais<\/span><\/span>,\u202f<\/span><\/span>Goodwin Procter LLP<\/span><\/span><\/i>\u00a0<\/span><\/li>\n
    • Brian Slater,\u202f<\/span><\/span>Kramer Levin\u00a0<\/span><\/span><\/span><\/i>Naftalis<\/span><\/span><\/i>\u00a0<\/span>& Frankel LLP<\/span><\/span><\/i>\u00a0<\/span><\/li>\n
    • Bruce Wexler,\u202f<\/span><\/span>Paul Hastings LLP<\/span><\/span><\/i>\u00a0<\/span><\/li>\n<\/ul>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

      Developers for\u00a0biosimilars\u00a0face not only stiff technical and manufacturing challenges, but […]<\/p>\n","protected":false},"author":72,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-21363","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"yoast_head":"\nWho Will "Dance" Now?\u00a0Biosimilars\u00a0After\u202fAmgen v. Sandoz\u00a0 - Intellectual Property Owners Association<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ipo.org\/index.php\/will-dance-now-biosimilars-after\u202famgen-v-sandoz\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Who Will "Dance" Now?\u00a0Biosimilars\u00a0After\u202fAmgen v. Sandoz\u00a0 - Intellectual Property Owners Association\" \/>\n<meta property=\"og:description\" content=\"Developers for\u00a0biosimilars\u00a0face not only stiff technical and manufacturing challenges, but [...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ipo.org\/index.php\/will-dance-now-biosimilars-after\u202famgen-v-sandoz\/\" \/>\n<meta property=\"og:site_name\" content=\"Intellectual Property Owners Association\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/IPOAssociation\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-07-12T14:00:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2017-08-07T17:24:51+00:00\" \/>\n<meta name=\"author\" content=\"Michael Marion\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ipo\" \/>\n<meta name=\"twitter:site\" content=\"@ipo\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Michael Marion\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ipo.org\\\/index.php\\\/will-dance-now-biosimilars-after%e2%80%afamgen-v-sandoz\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ipo.org\\\/index.php\\\/will-dance-now-biosimilars-after%e2%80%afamgen-v-sandoz\\\/\"},\"author\":{\"name\":\"Michael Marion\",\"@id\":\"https:\\\/\\\/ipo.org\\\/#\\\/schema\\\/person\\\/b2b29aa393fbb03aea9dab179a9c936e\"},\"headline\":\"Who Will “Dance” Now?\u00a0Biosimilars\u00a0After\u202fAmgen v. Sandoz\u00a0\",\"datePublished\":\"2017-07-12T14:00:34+00:00\",\"dateModified\":\"2017-08-07T17:24:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ipo.org\\\/index.php\\\/will-dance-now-biosimilars-after%e2%80%afamgen-v-sandoz\\\/\"},\"wordCount\":182,\"publisher\":{\"@id\":\"https:\\\/\\\/ipo.org\\\/#organization\"},\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ipo.org\\\/index.php\\\/will-dance-now-biosimilars-after%e2%80%afamgen-v-sandoz\\\/\",\"url\":\"https:\\\/\\\/ipo.org\\\/index.php\\\/will-dance-now-biosimilars-after%e2%80%afamgen-v-sandoz\\\/\",\"name\":\"Who Will \\\"Dance\\\" Now?\u00a0Biosimilars\u00a0After\u202fAmgen v. Sandoz\u00a0 - Intellectual Property Owners Association\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ipo.org\\\/#website\"},\"datePublished\":\"2017-07-12T14:00:34+00:00\",\"dateModified\":\"2017-08-07T17:24:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ipo.org\\\/index.php\\\/will-dance-now-biosimilars-after%e2%80%afamgen-v-sandoz\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ipo.org\\\/index.php\\\/will-dance-now-biosimilars-after%e2%80%afamgen-v-sandoz\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ipo.org\\\/index.php\\\/will-dance-now-biosimilars-after%e2%80%afamgen-v-sandoz\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ipo.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Who Will “Dance” Now?\u00a0Biosimilars\u00a0After\u202fAmgen v. Sandoz\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ipo.org\\\/#website\",\"url\":\"https:\\\/\\\/ipo.org\\\/\",\"name\":\"Intellectual Property Owners Association\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/ipo.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ipo.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ipo.org\\\/#organization\",\"name\":\"Intellectual Property Owners Association\",\"url\":\"https:\\\/\\\/ipo.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/ipo.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ipo.org\\\/wp-content\\\/uploads\\\/2019\\\/06\\\/ipo_logo.png\",\"contentUrl\":\"https:\\\/\\\/ipo.org\\\/wp-content\\\/uploads\\\/2019\\\/06\\\/ipo_logo.png\",\"width\":570,\"height\":226,\"caption\":\"Intellectual Property Owners Association\"},\"image\":{\"@id\":\"https:\\\/\\\/ipo.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/IPOAssociation\\\/\",\"https:\\\/\\\/x.com\\\/ipo\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ipoassociation\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ipo.org\\\/#\\\/schema\\\/person\\\/b2b29aa393fbb03aea9dab179a9c936e\",\"name\":\"Michael Marion\",\"description\":\"1819\",\"sameAs\":[\"https:\\\/\\\/ipo.org\"],\"url\":\"https:\\\/\\\/ipo.org\\\/index.php\\\/author\\\/michael-309\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Who Will \"Dance\" Now?\u00a0Biosimilars\u00a0After\u202fAmgen v. Sandoz\u00a0 - Intellectual Property Owners Association","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ipo.org\/index.php\/will-dance-now-biosimilars-after\u202famgen-v-sandoz\/","og_locale":"en_US","og_type":"article","og_title":"Who Will \"Dance\" Now?\u00a0Biosimilars\u00a0After\u202fAmgen v. Sandoz\u00a0 - Intellectual Property Owners Association","og_description":"Developers for\u00a0biosimilars\u00a0face not only stiff technical and manufacturing challenges, but [...]","og_url":"https:\/\/ipo.org\/index.php\/will-dance-now-biosimilars-after\u202famgen-v-sandoz\/","og_site_name":"Intellectual Property Owners Association","article_publisher":"https:\/\/www.facebook.com\/IPOAssociation\/","article_published_time":"2017-07-12T14:00:34+00:00","article_modified_time":"2017-08-07T17:24:51+00:00","author":"Michael Marion","twitter_card":"summary_large_image","twitter_creator":"@ipo","twitter_site":"@ipo","twitter_misc":{"Written by":"Michael Marion","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ipo.org\/index.php\/will-dance-now-biosimilars-after%e2%80%afamgen-v-sandoz\/#article","isPartOf":{"@id":"https:\/\/ipo.org\/index.php\/will-dance-now-biosimilars-after%e2%80%afamgen-v-sandoz\/"},"author":{"name":"Michael Marion","@id":"https:\/\/ipo.org\/#\/schema\/person\/b2b29aa393fbb03aea9dab179a9c936e"},"headline":"Who Will “Dance” Now?\u00a0Biosimilars\u00a0After\u202fAmgen v. Sandoz\u00a0","datePublished":"2017-07-12T14:00:34+00:00","dateModified":"2017-08-07T17:24:51+00:00","mainEntityOfPage":{"@id":"https:\/\/ipo.org\/index.php\/will-dance-now-biosimilars-after%e2%80%afamgen-v-sandoz\/"},"wordCount":182,"publisher":{"@id":"https:\/\/ipo.org\/#organization"},"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/ipo.org\/index.php\/will-dance-now-biosimilars-after%e2%80%afamgen-v-sandoz\/","url":"https:\/\/ipo.org\/index.php\/will-dance-now-biosimilars-after%e2%80%afamgen-v-sandoz\/","name":"Who Will \"Dance\" Now?\u00a0Biosimilars\u00a0After\u202fAmgen v. Sandoz\u00a0 - Intellectual Property Owners Association","isPartOf":{"@id":"https:\/\/ipo.org\/#website"},"datePublished":"2017-07-12T14:00:34+00:00","dateModified":"2017-08-07T17:24:51+00:00","breadcrumb":{"@id":"https:\/\/ipo.org\/index.php\/will-dance-now-biosimilars-after%e2%80%afamgen-v-sandoz\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ipo.org\/index.php\/will-dance-now-biosimilars-after%e2%80%afamgen-v-sandoz\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ipo.org\/index.php\/will-dance-now-biosimilars-after%e2%80%afamgen-v-sandoz\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ipo.org\/"},{"@type":"ListItem","position":2,"name":"Who Will “Dance” Now?\u00a0Biosimilars\u00a0After\u202fAmgen v. Sandoz\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/ipo.org\/#website","url":"https:\/\/ipo.org\/","name":"Intellectual Property Owners Association","description":"","publisher":{"@id":"https:\/\/ipo.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ipo.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ipo.org\/#organization","name":"Intellectual Property Owners Association","url":"https:\/\/ipo.org\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipo.org\/#\/schema\/logo\/image\/","url":"https:\/\/ipo.org\/wp-content\/uploads\/2019\/06\/ipo_logo.png","contentUrl":"https:\/\/ipo.org\/wp-content\/uploads\/2019\/06\/ipo_logo.png","width":570,"height":226,"caption":"Intellectual Property Owners Association"},"image":{"@id":"https:\/\/ipo.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/IPOAssociation\/","https:\/\/x.com\/ipo","https:\/\/www.linkedin.com\/company\/ipoassociation\/"]},{"@type":"Person","@id":"https:\/\/ipo.org\/#\/schema\/person\/b2b29aa393fbb03aea9dab179a9c936e","name":"Michael Marion","description":"1819","sameAs":["https:\/\/ipo.org"],"url":"https:\/\/ipo.org\/index.php\/author\/michael-309\/"}]}},"_links":{"self":[{"href":"https:\/\/ipo.org\/index.php\/wp-json\/wp\/v2\/posts\/21363","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ipo.org\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ipo.org\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ipo.org\/index.php\/wp-json\/wp\/v2\/users\/72"}],"replies":[{"embeddable":true,"href":"https:\/\/ipo.org\/index.php\/wp-json\/wp\/v2\/comments?post=21363"}],"version-history":[{"count":1,"href":"https:\/\/ipo.org\/index.php\/wp-json\/wp\/v2\/posts\/21363\/revisions"}],"predecessor-version":[{"id":21364,"href":"https:\/\/ipo.org\/index.php\/wp-json\/wp\/v2\/posts\/21363\/revisions\/21364"}],"wp:attachment":[{"href":"https:\/\/ipo.org\/index.php\/wp-json\/wp\/v2\/media?parent=21363"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ipo.org\/index.php\/wp-json\/wp\/v2\/categories?post=21363"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ipo.org\/index.php\/wp-json\/wp\/v2\/tags?post=21363"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}